Current Neuro-Oncology
Volume
22 Number 8
30 April 2020
Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 8, 30 April
Maas
SLN, Abels ER, Van De Haar LL, Zhang X, Morsett L, Sil S, Guedes
J, Sen P, Prabhakar S, Hickman SE, Lai CP, Ting DT, Breakefield
XO, Broekman MLD, El Khoury J.
Glioblastoma
hijacks microglial gene expression to support tumor growth.
J
Neuroinflammation. 2020 Apr 16, 2020;17(1):120∟.
doi: 10.1186/s12974-020-01797-2∟.
PMID: 32299465∟.
Laboratory investigation. ˍ
Moser
O, Zimmermann M, Meyer U, Klapper W, Oschlies I, Schrappe M,
Attarbaschi A, Mann G, Niggli F, Spix C, Kontny U, Klingebiel T,
Reiter A, Burkhardt B, Woessmann W.
Second
malignancies after treatment of childhood non-Hodgkin lymphoma: a
report of the Berlin-Frankfurt-Muenster study
group.
Haematologica.
2020 Apr 16, 2021;106(5):1390-1400∟.
doi: 10.3324/haematol.2019.244780∟.
PMID: 32299903∟.
Observational
study. ˍ
Regueira
PSS, Cerejeira JMS.
Delirium
as the primary manifestation of glioblastoma multiforme: a report
of two cases.
Psychogeriatrics.
2020 Apr 16, 2020 Sep;20(5):782-784∟.
doi: 10.1111/psyg.12555∟.
PMID: 32297428∟.
Case
report. ˍ
Weathers
SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M,
Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison
R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G,
Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger
AB.
Glioblastoma-mediated
immune dysfunction limits CMV-specific T cells and therapeutic
responses; results from a Phase I/II trial.
Clin
Cancer Res. 2020 Apr 16, 2020;26(14):3565-3577∟.
doi: 10.1158/1078-0432.CCR-20-0176∟.
PMID: 32299815∟.
Interventional
study. ˍ
Bellat
V, Alcaina Y, Tung CH, Ting R, Michel A, Souweidane M, Law B.
A
Combined Approach of Convection-Enhanced Delivery of Peptide
Nanofiber Reservoir to Prolong Delivery of DM1 for Diffuse
Intrinsic Pontine Glioma Treatment.
Neuro
Oncol. 2020 Apr 17, 2020;22(10):1495-1504∟.
doi: 10.1093/neuonc/noaa101∟.
PMID: 32301996∟.
Laboratory
investigation. ˍ
Bette
S, Barz M, Ly Nham H, Huber T, Berndt M, Sales A, Schmidt-Graf F,
Meyer HS, Ryang YM, Meyer B, Zimmer C, Kirschke JS, Wiestler B,
Gempt J.
Image
Analysis Reveals Microstructural and Volumetric Differences in
Glioblastoma Patients with and without Preoperative
Seizures.
Cancers
(Basel).
2020 Apr 17, 2020;12(4):E994∟.
doi: 10.3390/cancers12040994∟.
PMID: 32316566∟.
Observational
study. ˍ
Zigiotto
L, Annicchiarico L, Corsini F, Vitali L, Falchi R, Dalpiaz C,
Rozzanigo U, Barbareschi M, Avesani P, Papagno C, Duffau H,
Chioffi F, Sarubbo S.
Effects
of supra-total resection in neurocognitive and oncological outcome
of high-grade gliomas comparing asleep and awake surgery.
J
Neurooncol. 2020 Apr 17, 2020;148(1):97-108∟.
doi: 10.1007/s11060-020-03494-9∟.
PMID: 32303975∟.
Observational
study. ˍ
Dhall
G, O'Neil SH, Ji L, Haley K, Whitaker AM, Nelson MD, Gilles F,
Gardner SL, Allen JC, Cornelius AS, Pradhan K, Garvin JH,
Olshefski RS, Hukin J, Comito M, Goldman S, Atlas MP, Walter AW,
Sands S, Sposto R, Finlay JL.
Excellent
Outcome of Young Children with Nodular Desmoplastic
Medulloblastoma Treated on "Head Start" III: A
Multi-Institutional, Prospective Clinical Trial.
Neuro
Oncol.
2020
Apr 18, 2020;22(12):1862-1872∟.
doi: 10.1093/neuonc/noaa102∟.
PMID: 32304218∟.
Interventional
study. ˍ
Guberina
N, Pöttgen C, Kebir S, Lazaridis L, Scharmberg C, Lübcke
W, Niessen M, Guberina M, Scheffler B, Jendrossek V, Jabbarli R,
Pierscianek D, Sure U, Schmidt T, Oster C, Hau P, Grosu AL,
Stuschke M, Glas M, Nour Y, Lüdemann L.
Combined
radiotherapy and concurrent tumor treating fields (TTFields) for
glioblastoma: Dosimetric consequences on non-coplanar IMRT as
initial results from a phase I trial.
Radiat
Oncol. 2020 Apr 19, 2020;15(1):83∟.
doi: 10.1186/s13014-020-01521-7∟.
PMID: 32307022∟.
Interventional
study. ˍ
Assi
HI, Hilal L, Abu-Gheida I, Berro J, Sukhon F, Skaf G, Geara F,
Boulos F, Charafeddine M, Tabbarah A, Khoury J, Najjar
M.
Demographics
and outcomes of meningioma patients treated at a tertiary care
center in the Middle East.
Clin
Neurol Neurosurg.
2020
Apr 20, 2020;195:105846∟.
doi: 10.1016/j.clineuro.2020.105846∟.
PMID: 32334046∟.
Observational
study. ˍ
*
Carminucci
A, Tejero R, Huang Y, Danish S, Friedel RH, Foty R.
Teaching
an Old Drug New Tricks: Dexamethasone as an In Vivo Inhibitor of
Glioblastoma Dispersal.
Cureus.
2020 Apr 20, 2020;12(4):e7749∟.
doi: 10.7759/cureus.7749∟.
PMID: 32455066∟.
Laboratory
investigation. ˍ
Bokstein
F, Blumenthal D, Limon D, Harosh CB, Ram Z, Grossman R.
Concurrent
Tumor Treating Fields (TTFields) and Radiation Therapy for Newly
Diagnosed Glioblastoma: A Prospective Safety and Feasibility
Study.
Front
Oncol. 2020 Apr 21, 2020;10:411∟.
doi: 10.3389/fonc.2020.00411∟.
PMID: 32373508∟.
Interventional
study.
ˍ
Maiuri
F, Mariniello G, Peca C, Guadagno E, Corvino S, d'Avanzo S, Del
Basso De Caro M, de Divitiis O.
Multicentric
and diffuse recurrences of meningiomas.
Br
J Neurosurg.
2020
Apr 21, 2020;34(4):439-446∟.
doi: 10.1080/02688697.2020.1754335∟.
PMID: 32312105∟.
Observational
study. ˍ
Maynard
J, Okuchi S, Wastling S, Busaidi AA, Almossawi O, Mbatha W,
Brandner S, Jaunmuktane Z, Koc AM, Mancini L, Jäger R, Thust
S.
World
Health Organization Grade II/III Glioma Molecular Status:
Prediction by MRI Morphologic Features and Apparent Diffusion
Coefficient.
Radiology.
2020 Apr 21, 2020;296(1):111-121∟.
doi: 10.1148/radiol.2020191832∟.
PMID: 32315266∟.
Observational
study. ˍ
Stein
M, Dohmen H, Wölk B, Eberle F, Kolodziej M, Acker T, Uhl E,
Jensen A.
Case
Report of Complete Radiological Response of a Thalamic
Glioblastoma After Treatment With Proton Therapy Followed by
Temozolomide and Tumor-Treating Fields.
Front
Oncol. 2020 Apr 21, 2020;10:477∟.
doi: 10.3389/fonc.2020.00477∟.
PMID: 32373516∟.
Case
report. ˍ
Troya-Castilla
M, Kaen A, Márquez-Rivas FJ, Cossio PI, Díaz FR,
Narros Gimenez JL, Gonzalez-Pombo M, Cancela P, Fernández-Nogueras
MS, Arráez MÁ.
Impact
of early re-operation on the prognosis of patients operated on for
glioblastoma.
World
Neurosurg. 2020 Apr 21, 2020;139:e592-e600∟.
doi: 10.1016/j.wneu.2020.04.072∟.
PMID: 32330620∟.
Observational
study. ˍ
Cluceru
J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM,
Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P,
Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, Lupo JM.
Recurrent
tumor and treatment-induced effects have different MR signatures
in contrast enhancing and non-enhancing lesions of high-grade
gliomas.
Neuro
Oncol. 2020 Apr 22, 2020;22(10):1516-1526∟.
doi: 10.1093/neuonc/noaa094∟.
PMID: 32319527∟.
Observational
study. ˍ
Saeed
AM, Khairnar R, Sharma AM, Larson GL, Tsai HK, Wang CJ, Halasz LM,
Chinnaiyan P, Vargas CE, Mishra MV.
Clinical
Outcomes in Patients with Recurrent Glioblastoma Treated with
Proton Beam Therapy Reirradiation: Analysis of the
Multi-Institutional Proton Collaborative Group Registry.
Adv
Radiat Oncol. 2020 Apr 22, 2020;5(5):978-983∟.
doi: 10.1016/j.adro.2020.03.022∟.
PMID:
33083661∟.
Observational
study.
ˍ
Chiang
J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, Klimo P Jr, Boop FA,
Baker SJ, Gajjar A, Merchant TE, Ellison DW, Broniscer A, Patay Z,
Tinkle CL.
Clinical,
imaging, and molecular analysis of pediatric pontine tumors
lacking characteristic imaging features of DIPG.
Acta
Neuropathol Commun. 2020 Apr 23, 2020;8(1):57∟.
doi: 10.1186/s40478-020-00930-9∟.
PMID: 32326973∟.
Observational
study.
ˍ
Darvishi
P, Batchala PP, Patrie JT, Poisson LM, Lopes MB, Jain R, Fadul CE,
Schiff D, Patel SH.
Prognostic
Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma
Molecular Subtypes.
AJNR
Am J Neuroradiol. 2020 Apr 23, 2020;41(5):815-821∟.
doi: 10.3174/ajnr.A6511∟.
PMID: 32327434∟.
Observational
study.
ˍ
Feraco
P, Bacci A, Ferrazza P, van den Hauwe L, Pertile R, Girlando S,
Barbareschi M, Gagliardo C, Morganti AG, Petralia B.
Magnetic
Resonance Imaging Derived Biomarkers of IDH Mutation Status and
Overall Survival in Grade III Astrocytomas.
Diagnostics
(Basel).
2020 Apr 23, 2020;10(4):E247∟.
doi: 10.3390/diagnostics10040247∟.
PMID:
32340318∟.
Observational
study.
ˍ
Hong
JB, Roh TH, Kang SG, Kim SH, Moon JH, Kim EH, Ahn SS, Choi HJ, Cho
J, Suh CO, Chang JH.
Survival,
Prognostic Factors, and Volumetric Analysis of Extent of Resection
for Anaplastic Gliomas.
Cancer
Res Treat. 2020 Apr 23, 2020;52(4):1041-1049∟.
doi: 10.4143/crt.2020.057∟.
PMID: 32324987∟.
Observational
study. ˍ
Wang
X, Li F, Wang D, Zeng Q.
Diffusion
kurtosis imaging combined with molecular markers as a
comprehensive approach to predict overall survival in patients
with gliomas.
Eur
J Radiol. 2020 Apr 23, 2020;128:108985∟.
doi: 10.1016/j.ejrad.2020.108985∟.
PMID: 32361603∟.
Observational
study. ˍ
Balana
C, Vaz MA, Sepúlveda JM, Mesia C, Del Barco S, Pineda E,
Muñoz-Langa J, Estival A, de Las Peñas R, Fuster J,
Gironés R, Navarro LM, Gil-Gil M, Alonso M, Herrero A,
Peralta S, Olier C, Perez-Segura P, Covela M, Martinez-García
M, Berrocal A, Gallego O, Luque R, Perez-Martín FJ, Esteve
A, Munne N, Domenech M, Villa S, Sanz C, Carrato C.
A
phase II randomized, multicenter, open-label trial of continuing
adjuvant temozolomide beyond six cycles in patients with
glioblastoma (GEINO 14-01).
Neuro
Oncol. 2020 Apr 24, 2020;22(12):1851-1861∟.
doi: 10.1093/neuonc/noaa107∟.
PMID:
32328662∟.
Interventional
study.
ˍ
Bergmann
N, Delbridge C, Gempt J, Feuchtinger A, Walch A, Schirmer L, Bunk
W, Aschenbrenner T, Liesche-Starnecker F, Schlegel J.
The
Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of
Glioblastoma Multiforme: A Regional Immunohistochemistry
Analysis.
Front
Oncol. 2020 Apr 24, 2020;10:494∟.
doi: 10.3389/fonc.2020.00494∟.
PMID: 32391260∟.
Laboratory
investigation. ˍ
Loong
HH, Wong AM, Chan DT, Cheung MS, Chow C, Ding X, Chan AK, Johnston
PA, Lau JY, Poon WS, Wong N.
Patient-derived
tumor organoid predicts drugs response in glioblastoma: A step
forward in personalized cancer therapy?
J
Clin Neurosci.
2020
Apr 24, 2020;78:400-402∟.
doi: 10.1016/j.jocn.2020.04.107∟.
PMID: 32340843∟.
Case
report. ˍ
Mynarek
M, von Hoff K, Pietsch T, Ottensmeier H, Warmuth-Metz M, Bison B,
Pfister S, Korshunov A, Sharma T, Jaeger N, Ryzhova M, Zheludkova
O, Golanov A, Rushing EJ, Hasselblatt M, Koch A, Schüller U,
von Deimling A, Sahm F, Sill M, Riemenschneider MJ, Dohmen H,
Monoranu CM, Sommer C, Staszewski O, Mawrin C, Schittenhelm J,
Brück W, Filipski K, Hartmann C, Meinhardt M, Pietschmann K,
Haberler C, Slavc I, Gerber NU, Grotzer M, Benesch M, Schlegel PG,
Deinlein F, von Bueren AO, Friedrich C, Juhnke BO, Obrecht D,
Fleischhack G, Kwiecien R, Faldum A, Kortmann RD, Kool M,
Rutkowski S.
Nonmetastatic
Medulloblastoma of Early Childhood: Results From the Prospective
Clinical Trial HIT-2000 and An Extended Validation Cohort.
J
Clin Oncol.
2020
Apr 24, 2020;38(18):2028-2040∟.
doi: 10.1200/JCO.19.03057∟.
PMID: 32330099∟.
Interventional
study.
ˍ
Capo
G, Skrap M, Guarracino I, Isola M, Battistella C, Ius T, Tomasino
B.
Cognitive
Functions in Repeated Glioma Surgery.
Cancers
(Basel).
2020 Apr 26, 2020;12(5):E1077∟.
doi: 10.3390/cancers12051077∟.
PMID:
32357421∟.
Observational
study. ˍ
Brazil
L, Swampillai AL, Mak KM, Edwards D, Mesiri P, Clifton-Hadley L,
Shaffer R, Lewis J, Watts C, Jeffries S, Gkogkou P, Chalmers AJ,
Fersht NL, Hackshaw A, Short SC.
Hydroxychloroquine
and short-course radiotherapy in elderly patients with newly
diagnosed high-grade glioma: a randomized phase II
trial.
Neurooncol
Adv. 2020 Apr 27, 2020;2(1):vdaa046∟.
doi: 10.1093/noajnl/vdaa046∟.
PMID: 32642699∟.
Interventional
study. ˍ
Donovan
LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL,
Manno A, Srikanthan D, Gad AZ, Van Ommeren R, Przelicki D, Richman
C, Ramaswamy V, Daniels C, Pallota JG, Douglas T, Joynt ACM,
Haapasalo J, Nor C, Vladoi:u MC, Kuzan-Fischer CM, Garzia L, Mack
SC, Varadharajan S, Baker ML, Hendrikse L, Ly M, Kharas K, Balin
P, Wu X, Qin L, Huang N, Stucklin AG, Morrissy AS, Cavalli FMG,
Luu B, Suarez R, De Antonellis P, Michealraj A, Rastan A, Hegde M,
Komosa M, Sirbu O, Kumar SA, Abdullaev Z, Faria CC, Yip S, Hukin
J, Tabori U, Hawkins C, Aldape K, Daugaard M, Maris JM, Sorensen
PH, Ahmed N, Taylor MD.
Locoregional
delivery of CAR T cells to the cerebrospinal fluid for treatment
of metastatic medulloblastoma and ependymoma.
Nat
Med.
2020
Apr 27;26(5):720‐731∟.
doi: 10.1038/s41591-020-0827-2∟.
PMID: 32341580∟.
Laboratory
investigation.
ˍ
Mair
MJ, Wöhrer A, Furtner J, Simonovska A, Kiesel B, Oberndorfer
S, Ungersböck K, Marosi C, Sahm F, Hainfellner JA, Rössler
K, Preusser M, Widhalm G, Berghoff AS.
Clinical
characteristics and prognostic factors of adult patients with
pilocytic astrocytoma.
J
Neurooncol.
2020
Apr 27, 2020;148(1):187-198∟.
doi: 10.1007/s11060-020-03513-9∟.
PMID: 32342331∟.
Observational
study. ˍ
Tabrizi
S, Trippa L, Cagney D, Tanguturi S, Ventz S, Fell G, Wen PY,
Alexander BM, Rahman R.
A
Quantitative Framework for Modeling COVID-19 Risk During Adjuvant
Therapy Using Pub Randomized Trials of Glioblastoma in the
Elderly.
Neuro
Oncol. 2020 Apr 27, 2020;22(7):918-927∟.
doi: 10.1093/neuonc/noaa111∟.
PMID: 32339235∟.
Observational
study. ˍ
Press
RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, Morgan
TM, Behera M, Sengupta S, Voloschin AD, Olson JJ, Hasan S,
Blumenthal DT, Curran WJ, Eaton BR, Shu HG, Zhong J.
Optimal
timing of chemoradiotherapy after surgical resection of
glioblastoma: Stratification by validated prognostic
classification.
Cancer.
2020
Apr 28, 2020;126(14):3255-3264∟.
doi: 10.1002/cncr.32797∟.
PMID: 32342992∟.
Observational
study. ˍ
Ramakrishnan
V, Xu B, Akers J, Nguyen T, Ma J, Dhawan S, Ning J, Mao Y, Hua W,
Kokkoli E, Furnari F, Carter BS, Chen CC.
Radiation-induced
extracellular vesicle (EV) release of miR-603 promotes
IGF1-mediated stem cell state in glioblastomas.
EBioMedicine.
2020 Apr 28, 2020;55:102736∟.
doi: 10.1016/j.ebiom.2020.102736∟.
PMID: 32361246∟.
Laboratory
investigation. ˍ
Suradom
C, Suttajit S, Soontornpun A, Pinyopornpanish M.
Frontal
lobe meningioma presenting with schizophrenia-like symptoms: an
organic cause of psychotic disorder.
BMJ
Case Rep. 2020 Apr 28, 2020;13(4):e234526∟.
doi: 10.1136/bcr-2020-234526∟.
PMID: 32350055∟.
Case
report. ˍ
Zhao
K, Sun G, Wang Q, Xue Z, Liu G, Xia Y, Yao A, Zhao Y, You N, Yang
C, Xu B.
The
Diagnostic Value of Conventional MRI and CT Features in the
Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO
Grade II Gliomas.
Acad
Radiol. 2020 Apr 28, 2020;28(7):e189-e198∟.
doi: 10.1016/j.acra.2020.03.008∟.
PMID: 32359929∟.
Observational
study. ˍ
Alan
O, Telli TA, Tuylu TB, Arikan R, Demircan NC, Ercelep O, Kaya S,
Babacan NA, Atasoy BM, Bozkurt S, Bayri Y, Gul D, Ekinci G, Ziyal
I, Dane F, Yumuk PF.
Prognostic
factors in progressive high-grade glial tumors treated with
systemic approach: A single center experience.
J
Oncol Pharm Pract. 2020 Apr 29, 2021;27(2):329-339∟.
doi: 10.1177/1078155220920684∟.
PMID: 32349641∟.
Observational
study. ˍ
Brown
DA, Hanalioglu S, Chaichana K, Duffau H.
Transcorticosubcortical
Approach for Left Posterior Mediobasal Temporal Region Gliomas: A
Case Series and Anatomic Review of Relevant White Matter
Tracts.
World
Neurosurg. 2020 Apr 29, 2020;139:e737-e747∟.
doi: 10.1016/j.wneu.2020.04.147∟.
PMID: 32360919∟.
Case
report. ˍ
Fang
S, Li Y, Wang Y, Zhang Z, Jiang T.
Awake
craniotomy for gliomas involving motor-related areas:
classification and function recovery.
J
Neurooncol. 2020 Apr 29, 2020;148(2):317-325∟.
doi: 10.1007/s11060-020-03520-w∟.
PMID: 32350781∟.
Observational
study. ˍ
Visani
M, Marucci G, Biase D, Giangaspero F, Buttarelli FR, Brandes AA,
Franceschi E, Acquaviva G, Ciarrocchi A, Rhoden KJ, Tallini G,
Pession A.
miR-196B-5P
and miR-200B-3P Are Differentially Expressed in Medulloblastomas
of Adults and Children.
Diagnostics
(Basel).
2020 Apr 29, 2020;10(5):E265∟.
doi: 10.3390/diagnostics10050265∟.
PMID: 32365560∟.
Laboratory
investigation. ˍ
Choi
MG, Lee JH, Lee MS, Suh SJ, Lee YS, Kang DG.
Primary
Gliosarcoma with Extracranial Metastasis.
Brain
Tumor Res Treat. 2020 Apr 30, 2020;8(1):53-56∟.
doi: 10.14791/btrt.2020.8.e9∟.
PMID: 32390354∟.
Case
report. ˍ
Choi
Y, Nam Y, Lee YS, Kim J, Ahn KJ, Jang J, Shin NY, Kim BS, Jeon SS.
IDH1
mutation prediction using MR-based radiomics in glioblastoma:
comparison between manual and fully automated deep learning-based
approach of tumor segmentation.
Eur
J Radiol. 2020 Apr 30, 2020;128:109031∟.
doi: 10.1016/j.ejrad.2020.109031∟.
PMID: 32417712∟.
Observational
study. ˍ
Kian
W, Roisman LC, Goldstein IM, Abo-Quider A, Samueli B, Wallach N,
Alguayn F, Shalata W, Levitas D, Belochitski O, Levin D, Fenig E,
Lavrenkov K, Tokar M, Peled N, Yakobson A.
Vismodegib
as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult
Medulloblastoma.
JCO
Precis Oncol. 2020 Apr 30, 2020;4:PO.19.00264∟.
doi: 10.1200/PO.19.00264∟.
PMID: 32923880∟.
Case
report.
ˍ
Kim
MS, Lim J, Shin HS, Cho KG.
Re-Irradiation
and Its Contribution to Good Prognosis in Recurrent Glioblastoma
Patients.
Brain
Tumor Res Treat. 2020 Apr 30, 2020;8(1):29-35∟.
doi: 10.14791/btrt.2020.8.e10∟.
PMID: 32390351∟.
Observational
study. ˍ
Robinson
GW, Gajjar A.
Genomics
Paves the Way for Better Infant Medulloblastoma Therapy.
J
Clin Oncol. 2020 Apr 30, 2020;38(18):2010-2013∟.
doi: 10.1200/JCO.20.00593∟.
PMID: 32352857∟.
Editorial.
ˍ
Refers
to:
Mynarek
M, et al., Nonmetastatic Medulloblastoma of Early Childhood:
Results From the Prospective Clinical Trial HIT-2000 and An
Extended Validation Cohort.
J Clin Oncol. 2020 Apr 24,
2020;38(18):2028-2040∟.
doi: 10.1200/JCO.19.03057∟.
PMID: 32330099∟.
Interventional
study.
ˍ
Sidaway
P.
Low-grade
glioma subtypes revealed.
Nat
Rev Clin Oncol.
2020 April 30;17(6):335∟.
doi: 10.1038/s41571-020-0380-4∟.
PMID: 32355316∟.
Comment.
ˍ
REFERS
TO:
Ryall
S, et al., Integrated Molecular and Clinical Analysis of 1,000
Pediatric Low-Grade Gliomas.
Cancer
Cell. 2020 Apr 13;37(4):569‐583.e5∟.
doi: 10.1016/j.ccell.2020.03.011∟.
PMID: 32289278∟.
Laboratory investigation, Observational study.
ˍ